Literature DB >> 27408981

Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Daniel Martinez-Ramirez1, Michael S Okun1, Michael S Jaffee1.   

Abstract

Parkinson's disease (PD) is a chronic and complex neurodegenerative disorder resulting in a mixture of motor and nonmotor symptoms. Psychosis develops in around 60% of PD patients during and can be one of the most challenging nonmotor symptoms. PD psychosis is considered the single greatest precipitant for nursing home placement. PD psychosis is an independent predictor of increased mortality, and there is no 'ideal' or universal treatment strategy. The treatment approach to PD psychosis should be tailored and individualized for each patient. In this review, we will discuss PD psychosis and provide practical treatment considerations for neurologists, psychiatrists and other healthcare professionals. We stress the importance of real-time communication between members of the healthcare team.

Entities:  

Keywords:  antipsychotics; hallucinations; parkinsonism; pimavanserin; psychosis

Mesh:

Year:  2016        PMID: 27408981      PMCID: PMC5066136          DOI: 10.2217/nmt-2016-0009

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  76 in total

1.  What predicts mortality in Parkinson disease?: a prospective population-based long-term study.

Authors:  E B Forsaa; J P Larsen; T Wentzel-Larsen; G Alves
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

2.  Visual symptoms in Parkinson's disease and Parkinson's disease dementia.

Authors:  Neil K Archibald; Mike P Clarke; Urs P Mosimann; David J Burn
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

3.  Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.

Authors:  Tomoko Oeda; Atsushi Umemura; Yuko Mori; Satoshi Tomita; Masayuki Kohsaka; Kwiyoung Park; Kimiko Inoue; Harutoshi Fujimura; Hiroshi Hasegawa; Hiroshi Sugiyama; Hideyuki Sawada
Journal:  Neurobiol Aging       Date:  2015-09-07       Impact factor: 4.673

4.  Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.

Authors:  William G Ondo; Ron Tintner; Kevin Dat Voung; Dejian Lai; George Ringholz
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

5.  Olfactory reference syndrome: an unusual delusion in a patient with Parkinson's disease.

Authors:  Anne Moroy; Frank Bellivier; Gilles Fénelon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

Review 6.  The expanding universe of disorders of the basal ganglia.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Maria Stamelou; Kailash P Bhatia; David J Burn
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

Review 7.  Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.

Authors:  Abhishek Lenka; Shyam Sundar Arumugham; Rita Christopher; Pramod Kumar Pal
Journal:  J Neurol Sci       Date:  2016-03-03       Impact factor: 3.181

8.  A 12-year population-based study of psychosis in Parkinson disease.

Authors:  Elin B Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Christopher G Goetz; Glenn T Stebbins; Dag Aarsland; Guido Alves
Journal:  Arch Neurol       Date:  2010-08

9.  Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.

Authors:  Hubert H Fernandez; Michael S Okun; Ramon L Rodriguez; Irene A Malaty; Janet Romrell; Anqi Sun; Samuel S Wu; Sandeep Pillarisetty; Anand Nyathappa; Stephan Eisenschenk
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

10.  A randomized controlled trial of quetiapine for psychosis in Parkinson's disease.

Authors:  Paul Shotbolt; Michael Samuel; Chris Fox; Anthony S David
Journal:  Neuropsychiatr Dis Treat       Date:  2009-06-10       Impact factor: 2.570

View more
  2 in total

Review 1.  Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson's Symptoms.

Authors:  Palanisamy Sivanandy; Tan Choo Leey; Tan Chi Xiang; Tan Chi Ling; Sean Ang Wey Han; Samantha Lia Anak Semilan; Phoon Kok Hong
Journal:  Int J Environ Res Public Health       Date:  2021-12-30       Impact factor: 3.390

Review 2.  Psychiatric Manifestation in Patients with Parkinson's Disease.

Authors:  Ji Won Han; Yebin D Ahn; Won-Seok Kim; Cheol Min Shin; Seong Jin Jeong; Yoo Sung Song; Yun Jung Bae; Jong-Min Kim
Journal:  J Korean Med Sci       Date:  2018-11-01       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.